Skip to content
Medxy AI
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • MedXY story
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • MedXY story
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • isosorbide mononitrate
Comparative Effects of Nicorandil, Isosorbide Mononitrate, and Diltiazem on Radial Artery Graft Patency After CABG: Insights from the ASRAB-Pilot Trial
Posted inClinical Updates Wellness & Lifestyle

Comparative Effects of Nicorandil, Isosorbide Mononitrate, and Diltiazem on Radial Artery Graft Patency After CABG: Insights from the ASRAB-Pilot Trial

Posted by By MedXY 08/17/2025
The ASRAB-Pilot trial demonstrates that nicorandil and isosorbide mononitrate reduce radial artery graft failure rates post-CABG compared to diltiazem, highlighting potential advances in antispastic therapy for graft preservation.
Read More
  • Common Misunderstandings About Insomnia and Practical Sleep Recommendations
  • Unraveling Insomnia: Debunking Nine Common Myths and Finding Real Solutions
  • Childhood Verbal and Physical Abuse Harm Adult Mental Health
  • Exploring the Gut Microbiota-Insomnia Connection: Evidence and Controversies
  • Advancing Breast Cancer Detection: AI Identifies Missed Interval Cancers on Mammograms
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

AI Alzheimer's disease artificial intelligence blood pressure breast cancer cardiovascular health cardiovascular risk clinical trial COPD Dementia diabetes diet dinh dưỡng exercise health healthcare heart failure HFpEF HIV Hypertension immunotherapy longevity MASLD men's health mental health NAFLD nutrition obesity Pregnancy prevention public health randomized controlled trial randomized trial sexual health sleep stroke sức khỏe sức khỏe tình dục treatment type 2 diabetes weight loss wellness women's health 肥満 運動

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top